Loading...
A Case of Atypical Hemolytic Uremic Syndrome Successfully Treated with Eculizumab
Atypical hemolytic uremic syndrome (aHUS) is a rare thrombotic microangiopathy (TMA) characterized by the triad of hemolytic anemia, thrombocytopenia, and acute renal failure. Eculizumab, a monoclonal complement C5 antibody which prevents the induction of the terminal complement cascade, has recentl...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
S. Karger AG
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3924711/ https://ncbi.nlm.nih.gov/pubmed/24570684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000357520 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|